MarginsXMarginsX
Home › Markets › Health Care › SPRC

SciSparc Ltd. (SPRC)

SPRC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.3307
-10.62% on the day
Market cap
$815K
Nano cap
Revenue · 2025
$856K
-34.5% on 2024
Net income · 2025
-$12.2M
-1422.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1611746/000121390026049322/0001213900-26-049322-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSPRC on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0001611746
SEC industry codePharmaceutical Preparations
Incorporated inIsrael

Financials · 2025

LineValue
Revenue$856K
Net income-$12.2M
Operating income-$8.4M
Net margin-1422.8%
Operating margin-978.3%
Revenue growth-34.5%
Cash$4.6M
Total assets$7.6M
P/E (computed)Net income was not positive
P/S (computed)1.0×

Warning signs

Cash runway
13.3 months
$4.6M cash at December 31, 2025
Share count, 1 year
+537.9%
2024-12-31 to 2025-12-31 · +26313.2% over 3 years
Going-concern doubt
Yes
20-F filed April 29, 2026
Insider net buying, 12 months
-$5K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about our ability to continue as a going concern."
20-F 2026-04-29
Cash and burn$4.6M cash; operating cash flow -$1.0M a quarter.Report 2025-12-31
Shares outstandingNo cover-page share count in XBRLCover page 2025-12-31
Reverse splits, 3 years2; latest 1-for-9 on 2026-03-04Source 2026-03-04
Shelf and offerings, 12 months3 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-01-14
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBrightman Almagor Zohar & Co., Tel Aviv, IsraelPCAOB Form AP 2026-06-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $5K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$856K-$12.2M-$4.1M$4.6M$356K$856K20-F 2026-04-29
FY 2024
2024-12-31
$1.3M-$6.3M-$5.1M$1.5MNo debt tags$1.3M20-F 2025-04-24
FY 2023
2023-12-31
$2.9M-$5.1M-$5.9M$2.1MNo debt tags$2.9M20-F 2025-04-24
FY 2022
2022-12-31
$1.3M-$2.6M-$7.9M$3.6MNo debt tags$1.3M20-F 2025-04-24
FY 2021
2021-12-31
Not filed-$5.8M-$5.1M$6.9MNo debt tagsNeeds four quarters20-F/A 2024-05-02
FY 2020
2020-12-31
Not filed-$3.5M-$4.3M$7.8MNo debt tagsNeeds four quarters20-F 2021-03-30
FY 2019
2019-12-31
Not filed-$4.7M-$4.7M$870KNo debt tagsNeeds four quarters20-F 2021-03-30
FY 2018
2018-12-31
Not filed-$8.9M-$7.1M$1.5MNo debt tagsNeeds four quarters20-F 2021-03-30

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
F-32026-11-09
Latest annual report
ANNUAL REPORT
20-F2026-04-29
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-11-16

Source: SEC EDGAR submissions feed, 610 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-15.8%
1 month-91.0%
3 months-94.7%
Year to date-97.1%
1 year-98.5%
From 52-week high-98.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
OGENOragenics Inc.$0.1980-1.49%$893K
MTNBMatinas Biopharma Holdings Inc.$0.9270+3.00%$908K
GOVXGeoVax Labs Inc.$2.02+18.48%$1.1M
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$2.24-6.28%$1.2M
LABTLakewood-Amedex Biotherapeutics Inc.$0.2194-22.31%$520K
ELABPMGC Holdings Inc.$1.66+5.06%$1.3M
KAPAKairos Pharma Ltd.$0.4069-10.30%$1.4M
APVOAptevo Therapeutics Inc.$0.5486-7.66%$1.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier